
Michael Pervan
Examiner (ID: 11308, Phone: (571)272-0910 , Office: P/2621 )
| Most Active Art Unit | 2621 |
| Art Unit(s) | 2693, 2677, 2691, 2629, 2621 |
| Total Applications | 1288 |
| Issued Applications | 1041 |
| Pending Applications | 53 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7104873
[patent_doc_number] => 20050107256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them'
[patent_app_type] => utility
[patent_app_number] => 10/491649
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13380
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107256.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491649 | Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them | Sep 18, 2002 | Abandoned |
Array
(
[id] => 7256261
[patent_doc_number] => 20050075481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'T cell epitopes of the cyn d 1 allergen from bermuda grass pollen'
[patent_app_type] => utility
[patent_app_number] => 10/489972
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14422
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489972 | T cell epitopes of the cyn d 1 allergen from bermuda grass pollen | Sep 17, 2002 | Abandoned |
Array
(
[id] => 184874
[patent_doc_number] => 07648830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-19
[patent_title] => 'Method for determining the presence of bacteria resistant to cell lysing antibiotics'
[patent_app_type] => utility
[patent_app_number] => 10/490229
[patent_app_country] => US
[patent_app_date] => 2002-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 2968
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/648/07648830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490229 | Method for determining the presence of bacteria resistant to cell lysing antibiotics | Sep 1, 2002 | Issued |
Array
(
[id] => 141131
[patent_doc_number] => 07687074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-30
[patent_title] => 'Use of milk serum apoproteins in the treatment of microbial or viral infection'
[patent_app_type] => utility
[patent_app_number] => 10/487616
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 9248
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/687/07687074.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487616
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487616 | Use of milk serum apoproteins in the treatment of microbial or viral infection | Aug 19, 2002 | Issued |
Array
(
[id] => 737005
[patent_doc_number] => 07033838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method'
[patent_app_type] => utility
[patent_app_number] => 10/214323
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1833
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/033/07033838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214323 | Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method | Aug 7, 2002 | Issued |
Array
(
[id] => 7010809
[patent_doc_number] => 20050064525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Method of screening pigs for resistance to salmonellosis'
[patent_app_type] => utility
[patent_app_number] => 10/485024
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6322
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485024
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485024 | Method of screening pigs for resistance to salmonellosis | Jul 29, 2002 | Abandoned |
| 09/926596 | Fimbrial proteins | Jul 7, 2002 | Abandoned |
Array
(
[id] => 7010858
[patent_doc_number] => 20050064574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Novel plasmidic gene, ways of acquiring this gene, the amylolytic enzyme it encodes and its application'
[patent_app_type] => utility
[patent_app_number] => 10/488645
[patent_app_country] => US
[patent_app_date] => 2002-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2910
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064574.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488645
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488645 | Plasmidic gene, ways of acquiring this gene, the amylolytic enzyme it encodes and its application | Jun 25, 2002 | Issued |
Array
(
[id] => 9529784
[patent_doc_number] => 08753651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Capsular polysaccharide solubilisation and combination vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/481457
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 25
[patent_no_of_words] => 12975
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10481457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481457 | Capsular polysaccharide solubilisation and combination vaccines | Jun 19, 2002 | Issued |
Array
(
[id] => 7149534
[patent_doc_number] => 20040171013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Method for determining the nature of an infection'
[patent_app_type] => new
[patent_app_number] => 10/479656
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4969
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479656 | Method for determining the nature of an infection | Jun 2, 2002 | Issued |
Array
(
[id] => 4537159
[patent_doc_number] => 07875279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-25
[patent_title] => 'Inactivation of genes of the MEP pathway'
[patent_app_type] => utility
[patent_app_number] => 10/475510
[patent_app_country] => US
[patent_app_date] => 2002-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3567
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/875/07875279.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475510 | Inactivation of genes of the MEP pathway | Apr 12, 2002 | Issued |
Array
(
[id] => 5742821
[patent_doc_number] => 20060088546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens'
[patent_app_type] => utility
[patent_app_number] => 10/474853
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18734
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474853 | Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens | Apr 10, 2002 | Abandoned |
Array
(
[id] => 7378997
[patent_doc_number] => 20040028689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Probiotic recolonisation therapy'
[patent_app_type] => new
[patent_app_number] => 10/332986
[patent_app_country] => US
[patent_app_date] => 2003-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6062
[patent_no_of_claims] => 172
[patent_no_of_ind_claims] => 90
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028689.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332986
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332986 | Probiotic recolonisation therapy | Jul 24, 2001 | Issued |
Array
(
[id] => 9273124
[patent_doc_number] => 08637051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Compositions and methods for treatment of mucosal infections'
[patent_app_type] => utility
[patent_app_number] => 10/276829
[patent_app_country] => US
[patent_app_date] => 2001-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5616
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10276829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276829 | Compositions and methods for treatment of mucosal infections | May 20, 2001 | Issued |
Array
(
[id] => 7381869
[patent_doc_number] => 20040029127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Use of lactobacillus case in immunostimulatory peptides'
[patent_app_type] => new
[patent_app_number] => 10/276315
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5153
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276315 | Reinforcing systemic immune responses with lactobacillus casei | Apr 26, 2001 | Issued |
Array
(
[id] => 7795649
[patent_doc_number] => 08124355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Detection and identification of groups of bacteria'
[patent_app_type] => utility
[patent_app_number] => 10/470797
[patent_app_country] => US
[patent_app_date] => 2001-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5360
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470797
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470797 | Detection and identification of groups of bacteria | Jan 31, 2001 | Issued |
Array
(
[id] => 7168293
[patent_doc_number] => 20050202000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Novel remombinant staphylokinase derivant and its preparation method and application thereof'
[patent_app_type] => utility
[patent_app_number] => 10/182160
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8098
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182160 | Recombinant staphylokinase derivatives and the preparation and applications thereof | Jan 22, 2001 | Issued |
Array
(
[id] => 202079
[patent_doc_number] => 07632528
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-12-15
[patent_title] => 'Antimigraine combination comprising Sapindus and Emblica extracts'
[patent_app_type] => utility
[patent_app_number] => 10/276319
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10890
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276319 | Antimigraine combination comprising Sapindus and Emblica extracts | May 24, 2000 | Issued |